FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2042150292> ?p ?o ?g. }

• W2042150292 endingPage "327" @default.
• W2042150292 startingPage "320" @default.
• W2042150292 abstract "Apoptosis, or programmed cell death, is an active form of cell death that is initiated by a number of stimuli and is intricately regulated. Apoptosis in both excessive and reduced amounts has pathophysiologic implications. Accelerated programmed cell death has been observed in leukocytes among patients with chronic renal failure (CRF). This has been ascribed in part to the retention of uremic toxins. The Fas/Fas ligand (FasL) system is a key regulatory apoptotic pathway. Membrane-bound Fas is a cell-surface receptor that transduces apoptosis after interaction with membrane-bound or soluble FasL (sFasL). By contrast, soluble Fas (sFas) binds sFasL and inhibits its activity. In an attempt to examine the balance between these soluble factors in uremia, we measured soluble sFas and sFasL levels in the serum of healthy control subjects and patients with various degrees of CRF and examined the distribution of the various molecular mass fractions of these proteins in uremic serum. In brief, serum was obtained from 15 healthy volunteers, 17 patients with CRF, 11 patients undergoing maintenance hemodialysis (HD), and 7 patients undergoing peritoneal dialysis (PD). Serum sFas and sFasL were measured by enzyme-linked immunosorbent assay, and their molecular distribution was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by immunoblot. Compared with results in healthy control subjects, sFas levels were significantly higher in patients with CRF and in patients undergoing dialysis. There was a significant inverse correlation between sFas levels and creatinine clearance. Serum sFasL levels were not different among the four groups. However, the sFas-to-sFasL ratio was significantly lower in healthy control subjects as compared with patients with CRF and patients undergoing dialysis. Immunoblots and densitometric analyses of sFas and sFasL depicted a known 48-kd sFas, a known 27-kd sFasL, and a 60-kd sFas-sFasL protein aggregate signal. In conclusion, serum sFas levels are increased in patients with various degrees of CRF and may bind circulating sFasL, thereby minimizing mediation of cellular apoptosis." @default.
• W2042150292 created "2016-06-24" @default.
• W2042150292 creator A5007210792 @default.
• W2042150292 creator A5024181264 @default.
• W2042150292 creator A5034229606 @default.
• W2042150292 creator A5066015692 @default.
• W2042150292 creator A5068922252 @default.
• W2042150292 creator A5071458079 @default.
• W2042150292 creator A5074694483 @default.
• W2042150292 date "2000-10-01" @default.
• W2042150292 modified "2023-10-17" @default.
• W2042150292 title "Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure" @default.
• W2042150292 cites W1487397714 @default.
• W2042150292 cites W1558473055 @default.
• W2042150292 cites W1970997093 @default.
• W2042150292 cites W1973792489 @default.
• W2042150292 cites W1975291295 @default.
• W2042150292 cites W1975336660 @default.
• W2042150292 cites W1984456353 @default.
• W2042150292 cites W1985521400 @default.
• W2042150292 cites W2003783070 @default.
• W2042150292 cites W2009460398 @default.
• W2042150292 cites W2054881197 @default.
• W2042150292 cites W2070664130 @default.
• W2042150292 cites W2071524275 @default.
• W2042150292 cites W2090967709 @default.
• W2042150292 cites W2096747831 @default.
• W2042150292 cites W2116172091 @default.
• W2042150292 cites W2122978471 @default.
• W2042150292 cites W2127993518 @default.
• W2042150292 cites W2143996326 @default.
• W2042150292 cites W2164802863 @default.
• W2042150292 cites W2170625553 @default.
• W2042150292 cites W2187896211 @default.
• W2042150292 cites W2232248512 @default.
• W2042150292 cites W2265871020 @default.
• W2042150292 cites W4237099497 @default.
• W2042150292 cites W4237485903 @default.
• W2042150292 cites W92987635 @default.
• W2042150292 doi "https://doi.org/10.1067/mlc.2000.109318" @default.
• W2042150292 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11039853" @default.
• W2042150292 hasPublicationYear "2000" @default.
• W2042150292 type Work @default.
• W2042150292 sameAs 2042150292 @default.
• W2042150292 citedByCount "37" @default.
• W2042150292 countsByYear W20421502922012 @default.
• W2042150292 countsByYear W20421502922013 @default.
• W2042150292 countsByYear W20421502922015 @default.
• W2042150292 countsByYear W20421502922017 @default.
• W2042150292 countsByYear W20421502922022 @default.
• W2042150292 countsByYear W20421502922023 @default.
• W2042150292 crossrefType "journal-article" @default.
• W2042150292 hasAuthorship W2042150292A5007210792 @default.
• W2042150292 hasAuthorship W2042150292A5024181264 @default.
• W2042150292 hasAuthorship W2042150292A5034229606 @default.
• W2042150292 hasAuthorship W2042150292A5066015692 @default.
• W2042150292 hasAuthorship W2042150292A5068922252 @default.
• W2042150292 hasAuthorship W2042150292A5071458079 @default.
• W2042150292 hasAuthorship W2042150292A5074694483 @default.
• W2042150292 hasConcept C126322002 @default.
• W2042150292 hasConcept C134018914 @default.
• W2042150292 hasConcept C185592680 @default.
• W2042150292 hasConcept C190283241 @default.
• W2042150292 hasConcept C203014093 @default.
• W2042150292 hasConcept C2776635150 @default.
• W2042150292 hasConcept C2778063415 @default.
• W2042150292 hasConcept C2779978075 @default.
• W2042150292 hasConcept C3031857 @default.
• W2042150292 hasConcept C31573885 @default.
• W2042150292 hasConcept C55493867 @default.
• W2042150292 hasConcept C66008609 @default.
• W2042150292 hasConcept C71924100 @default.
• W2042150292 hasConceptScore W2042150292C126322002 @default.
• W2042150292 hasConceptScore W2042150292C134018914 @default.
• W2042150292 hasConceptScore W2042150292C185592680 @default.
• W2042150292 hasConceptScore W2042150292C190283241 @default.
• W2042150292 hasConceptScore W2042150292C203014093 @default.
• W2042150292 hasConceptScore W2042150292C2776635150 @default.
• W2042150292 hasConceptScore W2042150292C2778063415 @default.
• W2042150292 hasConceptScore W2042150292C2779978075 @default.
• W2042150292 hasConceptScore W2042150292C3031857 @default.
• W2042150292 hasConceptScore W2042150292C31573885 @default.
• W2042150292 hasConceptScore W2042150292C55493867 @default.
• W2042150292 hasConceptScore W2042150292C66008609 @default.
• W2042150292 hasConceptScore W2042150292C71924100 @default.
• W2042150292 hasIssue "4" @default.
• W2042150292 hasLocation W20421502921 @default.
• W2042150292 hasLocation W20421502922 @default.
• W2042150292 hasOpenAccess W2042150292 @default.
• W2042150292 hasPrimaryLocation W20421502921 @default.
• W2042150292 hasRelatedWork W1991383991 @default.
• W2042150292 hasRelatedWork W2024503661 @default.
• W2042150292 hasRelatedWork W2044683642 @default.
• W2042150292 hasRelatedWork W2048728216 @default.
• W2042150292 hasRelatedWork W2066728513 @default.
• W2042150292 hasRelatedWork W2069300823 @default.
• W2042150292 hasRelatedWork W2084186670 @default.
• W2042150292 hasRelatedWork W2105789996 @default.

• next